Cited by 156Receptor Mechanisms and SignalingCytokine Signaling Pathways and InteractionsProtein Kinase Regulation and GTPase Signaling

The DOI matches its Crossref record; 36 of the 37 references it cites were found in a registry or an index.

The fourth immunoglobulin domain of the stem cell factor receptor couples ligand binding to signal transduction

Open access

Blechman, Janna M, Lev, Sima, Barg, Jacob, Eisenstein, Miriam, Vaks, Baruch, Vogel, Zvi, Givol, David, Yarden, Yosef·1995·Cell

DOI 10.1016/0092-8674(95)90455-7

Open this paper in CoChat — free account

Abstract

Receptor dimerization is ubiquitous to the action of all receptor tyrosine kinases, and in the case of dimeric ligands, such as the stem cell factor (SCF), it was attributed to ligand bivalency. However, by using a dimerization-inhibitory monoclonal antibody to the SCF receptor, we confined a putative dimerization site to the nonstandard fourth immunoglobulin-like domain of the receptor. Deletion of this domain not only abolished ligand-induced dimerization and completely inhibited signal transduction, but also provided insights into the mechanism of the coupling of ligand binding to dimer formation. These results identify an intrinsic receptor dimerization site and suggest that similar sites may exist in other receptors.

Integrity signals

Registry

Crossref · 10.1016/0092-8674(95)90455-7

Cites

36 of 36 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

THE ATTRACTIONS OF PROTEINS FOR SMALL MOLECULES AND IONS
Scatchard, G. (1949) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1949.tb27297.x · Cited by 19,724
Signal transduction by receptors with tyrosine kinase activity
Ullrich, A., & Schlessinger, J. (1990) · Cell · doi:10.1016/0092-8674(90)90801-k · Cited by 5,435
Conformation of Polypeptides and Proteins
Ramachandran, G. N., & Sasisekharan, V. (1968) · Advances in protein chemistry · doi:10.1016/s0065-3233(08)60402-7 · Cited by 2,950
The Immunoglobulin Superfamily: Domains For Cell Surface Recognition
Williams, A., & Barclay, A. N. (1988) · Annual Review of Immunology · doi:10.1146/annurev.iy.06.040188.002121 · Cited by 2,270
A graphics model building and refinement system for macromolecules
Jones, T. A. (1978) · Journal of Applied Crystallography · doi:10.1107/s0021889878013308 · Cited by 1,833
Crystallographic refinement and atomic models of a human Fc fragment and its complex with fragment B of protein A from Staphylococcus aureus at 2.9- and 2.8-A resolution.
Deisenhofer, J. (1981) · Biochemistry · doi:10.1021/bi00512a001 · Cited by 1,539
Crystallographic refinement and atomic models of a human Fc fragment and its complex with fragment B of protein A from Staphylococcus aureus at 2.9- and 2.8-A resolution.
Deisenhofer, J. (1981) · PubMed · Cited by 1,422
Signal Transduction by the Platelet-Derived Growth Factor Receptor
Williams, L. T. (1989) · Science · doi:10.1126/science.2538922 · Cited by 644
Epidermal growth factor induces rapid, reversible aggregation of the purified epidermal growth factor receptor
Yarden, Y., & Schlessinger, J. (1987) · Biochemistry · doi:10.1021/bi00379a035 · Cited by 627
Self-citation
Molecular bases of dominant negative and loss of function mutations at the murine c‐kit/white spotting locus: W37, Wv, W41 and W.
Nocka, K. H., Tan, J. C., Chiu, E., Chu, T., Ray, P., Traktman, P., & Besmer, P. (1990) · The EMBO Journal · doi:10.1002/j.1460-2075.1990.tb08305.x · Cited by 588

Show all 37 references

Sorted by citations

Vascular endothelial growth factor (VEGF) and its receptors
Neufeld, G., Cohen, T., Gengrinovitch, S., & Gluzman‐Poltorak, Z. (1999) · The FASEB Journal · doi:10.1096/fasebj.13.1.9 · Cited by 3,511
Mechanism of Action and In Vivo Role of Platelet-Derived Growth Factor
Heldin, C., & Westermark, B. (1999) · Physiological Reviews · doi:10.1152/physrev.1999.79.4.1283 · Cited by 2,521
Dimerization of cell surface receptors in signal transduction
Heldin, C.-H. (1995) · Cell · doi:10.1016/0092-8674(95)90404-2 · Cited by 1,634
A Hierarchical Network of Interreceptor Interactions Determines Signal Transduction by Neu Differentiation Factor/Neuregulin and Epidermal Growth Factor
Tzahar, E., Waterman, H., Chen, X., Levkowitz, G., Karunagaran, D., Lavi, S., Ratzkin, B. J., & Yarden, Y. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.10.5276 · Cited by 1,039
Stem Cell Factor and Hematopoiesis
Broudy, V. C. (1997) · Blood · doi:10.1182/blood.v90.4.1345 · Cited by 876
Signal transduction via platelet-derived growth factor receptors
Heldin, C., Östman, A., & Rönnstrand, L. (1998) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/s0304-419x(98)00015-8 · Cited by 747
c-kit Ligand and Flt3 Ligand: Stem/Progenitor Cell Factors With Overlapping Yet Distinct Activities
Lyman, S. D., & Jacobsen, S. E. W. (1998) · Blood · doi:10.1182/blood.v91.4.1101 · Cited by 686
Adverse Prognostic Significance of KIT Mutations in Adult Acute Myeloid Leukemia With inv(16) and t(8;21): A Cancer and Leukemia Group B Study
Paschka, P., Marcucci, G., Ruppert, A. S., Mrózek, K., Chen, H., Kittles, R. A., Vukosavljevic, T., Perrotti, D., Vardiman, J. W., Carroll, A. J., et al. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2006.06.9500 · Cited by 661
Pathology and diagnostic criteria of gastrointestinal stromal tumors (GISTs): a review
Miettinen, M., Majidi, M., & Lasota, J. P. (2002) · European Journal of Cancer · doi:10.1016/s0959-8049(02)80602-5 · Cited by 545
Graded activation of fibroblast growth factor receptor 3 by mutations causing achondroplasia and thanatophoric dysplasia
Naski, M., Wang, Q., Xu, J.-S., & Ornitz, D. (1996) · Nature Genetics · doi:10.1038/ng0696-233 · Cited by 525
Crystal Structure at 1.7 Å Resolution of VEGF in Complex with Domain 2 of the Flt-1 Receptor
Wiesmann, C., Fuh, G., Christinger, H. W., Eigenbrot, C. W., Wells, J. A., & de Vos, A. M. (1997) · Cell · doi:10.1016/s0092-8674(00)80456-0 · Cited by 494
The role of VEGF receptors in angiogenesis; complex partnerships
Suarez, S., Zehnder-Fjällman, A. H. M., & Ballmer‐Hofer, K. (2006) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-005-5426-3 · Cited by 425
Early signaling pathways activated by c-Kit in hematopoietic cells
Linnekin, D. (1999) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/s1357-2725(99)00078-3 · Cited by 379
Structural Basis for Activation of the Receptor Tyrosine Kinase KIT by Stem Cell Factor
Yuzawa, S., Opatowsky, Y., Zhang, Z., Mandiyan, V., Lax, I., & Schlessinger, J. (2007) · Cell · doi:10.1016/j.cell.2007.05.055 · Cited by 359
Comparative analysis of the domestic cat genome reveals genetic signatures underlying feline biology and domestication
Montague, M. J., Li, G., Gandolfi, B., Khan, R., Aken, B. L., Searle, S. M. J., Minx, P., Hillier, L. W., Koboldt, D. C., Davis, B. W., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1410083111 · Cited by 340
Normal and Oncogenic Forms of the Receptor Tyrosine Kinase Kit
Lennartsson, J., Jelacic, T. M., Linnekin, D., & Shivakrupa, R. (2005) · Stem Cells · doi:10.1634/stemcells.2004-0117 · Cited by 320
Flt-1 but not KDR/Flk-1 tyrosine kinase is a receptor for placenta growth factor, which is related to vascular endothelial growth factor.
Sawano, A., Takahashi, T., Yamaguchi, S., Aonuma, M., & Shibuya, M. (1996) · PubMed · Cited by 290
c-Kit—A hematopoietic cell essential receptor tyrosine kinase
Edling, C. E., & Hallberg, B. (2007) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2006.12.005 · Cited by 270
Structure and dual function of vascular endothelial growth factor receptor-1 (Flt-1)
Shibuya, M. (2001) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/s1357-2725(01)00026-7 · Cited by 264
Requirements for Binding and Signaling of the Kinase Domain Receptor for Vascular Endothelial Growth Factor
Fuh, G., Li, B., Crowley, C. W., Cunningham, B. C., & Wells, J. A. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.18.11197 · Cited by 266
The SCF/KIT Pathway Plays a Critical Role in the Control of Normal Human Melanocyte Homeostasis
Grichnik, J. M., Burch, J. A., Burchette, J. L., & Shea, C. R. (1998) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.1998.00272.x · Cited by 242
Structure and function of VEGF receptors
Stuttfeld, E., & Ballmer‐Hofer, K. (2009) · IUBMB Life · doi:10.1002/iub.234 · Cited by 253
Bivalence of EGF‐like ligands drives the ErbB signaling network
Tzahar, E., Pinkas‐Kramarski, R., Moyer, J. D., Klapper, L. N., Alroy, I., Levkowitz, G., Shelly, M., Henis, S., Eisenstein, M., Ratzkin, B. J., et al. (1997) · The EMBO Journal · doi:10.1093/emboj/16.16.4938 · Cited by 228
Recent advances in the understanding of mastocytosis: the role of KIT mutations*
Órfão, A., García‐Montero, A. C., Sánchez‐Muñoz, L., & Escribano, L. (2007) · British Journal of Haematology · doi:10.1111/j.1365-2141.2007.06619.x · Cited by 221
Kit ligand and c-Kit have diverse roles during mammalian oogenesis and folliculogenesis
Hutt, K. J., McLaughlin, E. A., & Holland, M. K. (2006) · Molecular Human Reproduction · doi:10.1093/molehr/gal010 · Cited by 211
The Sema domain of Met is necessary for receptor dimerization and activation
Kong-Beltran, M., Stamos, J. L., & Wickramasinghe, D. (2004) · Cancer Cell · doi:10.1016/j.ccr.2004.06.013 · Cited by 208
Involvement of platelet-derived growth factor in disease: development of specific antagonists
Östman, A., & Heldin, C. (2001) · Advances in cancer research · doi:10.1016/s0065-230x(01)80010-5 · Cited by 200
The second immunoglobulin‐like domain of the VEGF tyrosine kinase receptor Flt‐1 determines ligand binding and may initiate a signal transduction cascade.
Davis-Smyth, T., Chen, H., Park, J., Presta, L. G., & Ferrara, N. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb00872.x · Cited by 200
Mapping of the Sites for Ligand Binding and Receptor Dimerization at the Extracellular Domain of the Vascular Endothelial Growth Factor Receptor FLT-1
Barleon, B., Totzke, F., Herzog, C., Blanke, S., Kremmer, E., Siemeister, G., Marmé, D., & Martiny‐Baron, G. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.16.10382 · Cited by 193
Pivotal Advance: Avian colony-stimulating factor 1 ( CSF-1 ), interleukin-34 ( IL-34 ), and CSF-1 receptor genes and gene products
Garceau, V., Smith, J., Paton, I. R., Davey, M. G., Fares, M. A., Sester, D. P., Burt, D. W., & Hume, D. A. (2010) · Journal of Leukocyte Biology · doi:10.1189/jlb.0909624 · Cited by 178
VEGF/VEGFR signalling as a target for inhibiting angiogenesis
Kiselyov, A. S., Balakin, K. V., & Tkachenko, S. E. (2006) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.16.1.83 · Cited by 176
Growth and Differentiation of Human Stem Cell Factor/Erythropoietin-Dependent Erythroid Progenitor Cells In Vitro
Panzenböck, B., Bartůněk, P., Mapara, M. Y., & Zenke, M. (1998) · Blood · doi:10.1182/blood.v92.10.3658 · Cited by 171
Structure and Function of Vascular Endothelial Growth Factor Receptor-1 and -2
Shibuya, M., Ito, N., & Claesson, L. (1999) · Current topics in microbiology and immunology · doi:10.1007/978-3-642-59953-8_4 · Cited by 160
Structure of a VEGF–VEGF receptor complex determined by electron microscopy
Ruch, C., Skiniotis, G., Steinmetz, M. O., Walz, T., & Ballmer‐Hofer, K. (2007) · Nature Structural & Molecular Biology · doi:10.1038/nsmb1202 · Cited by 155
Neu Differentiation Factor/Neuregulin Isoforms Activate Distinct Receptor Combinations
Pinkas‐Kramarski, R., Shelly, M., Glathe, S., Ratzkin, B. J., & Yarden, Y. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.32.19029 · Cited by 141
Crystal structure of human stem cell factor: Implication for stem cell factor receptor dimerization and activation
Zhang, Z., Zhang, R., Joachimiak, A., Schlessinger, J., & Kong, X. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.14.7732 · Cited by 137
Residues on Both Faces of the First Immunoglobulin Fold Contribute to Homophilic Binding Sites of PECAM-1/CD31
Newton, J. P., Buckley, C. D., Jones, E. Y., & Simmons, D. L. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.33.20555 · Cited by 131
The biology of Kit in disease and the application of pharmacogenetics
Akin, C., & Metcalfe, D. D. (2004) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2004.04.046 · Cited by 132
KIT SIGNAL TRANSDUCTION
Taylor, M. L., & Metcalfe, D. D. (2000) · Hematology/Oncology Clinics of North America · doi:10.1016/s0889-8588(05)70294-x · Cited by 130
c-Kit and c-kit mutations in mastocytosis and other hematological diseases
Boissan, M., Féger, F., Guillosson, J., & Arock, M. (2000) · Journal of Leukocyte Biology · doi:10.1002/jlb.67.2.135 · Cited by 123
Kit Receptor Dimerization Is Driven by Bivalent Binding of Stem Cell Factor
Lemmon, M. A., Pinchasi, D., Zhou, M., Lax, I., & Schlessinger, J. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.10.6311 · Cited by 122
Structural basis for stem cell factor–KIT signaling and activation of class III receptor tyrosine kinases
Liu, H., Chen, X., Focia, P. J., & He, X. L. (2007) · The EMBO Journal · doi:10.1038/sj.emboj.7601545 · Cited by 118
Structure of the active core of human stem cell factor and analysis of binding to its receptor Kit
Jiang, X., Gurel, O., Mendiaz, E. A., Stearns, G. W., Clogston, C. L., Lu, H. S., Osslund, T. D., Syed, R. S., Langley, K. E., & Hendrickson, W. A. (2000) · The EMBO Journal · doi:10.1093/emboj/19.13.3192 · Cited by 113
TrkA Immunoglobulin-Like Ligand Binding Domains Inhibit Spontaneous Activation of the Receptor
Arévalo, J. C., Conde, B., Hempstead, B. L., Chao, M. V., Martı́n-Zanca, D., & Pérez, P. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.16.5908-5916.2000 · Cited by 122
Distinct Subdomains of the EphA3 Receptor Mediate Ligand Binding and Receptor Dimerization
Lackmann, M., Oates, A. C., Dottori, M., Smith, F. M., Do, C., Power, M.-A., Kravets, L., & Boyd, A. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.32.20228 · Cited by 108
Expression of c‐KIT and Its Ligand, Stem Cell Factor, in Normal and Subfertile Human Testicular Tissue
Sandlow, J. I., FENG, H., Cohen, M. B., & Sandra, A. (1996) · Journal of Andrology · doi:10.1002/j.1939-4640.1996.tb01806.x · Cited by 104
Extracellular assembly and activation principles of oncogenic class III receptor tyrosine kinases
Verstraete, K., & Savvides, S. N. (2012) · Nature reviews. Cancer · doi:10.1038/nrc3371 · Cited by 102
KIT exon 8 mutations associated with core-binding factor (CBF)–acute myeloid leukemia (AML) cause hyperactivation of the receptor in response to stem cell factor
Kohl, T. M., Schnittger, S., Ellwart, J. W., Hiddemann, W., & Spiekermann, K. (2004) · Blood · doi:10.1182/blood-2004-06-2068 · Cited by 97
Inhibitory effect of imatinib on normal progenitor cells in vitro
Bartolović, K., Balabanov, S., Hartmann, U., Komor, M., Boehmler, A. M., Bühring, H., Möhle, R., Hoelzer, D. F., Kanz, L., Hofmann, W., et al. (2003) · Blood · doi:10.1182/blood-2003-05-1535 · Cited by 97
Ligand-induced dimerization of growth factor receptors: Variations on the theme
HELDIN, C. (1996) · Cytokine & Growth Factor Reviews · doi:10.1016/1359-6101(96)00002-0 · Cited by 92
Flow Cytometric Analysis
McKay, P. F. (2000) · Methods in molecular medicine · doi:10.1385/1-59259-076-4:407 · Cited by 92
Contacts between membrane proximal regions of the PDGF receptor ectodomain are required for receptor activation but not for receptor dimerization
Yang, Y., Yuzawa, S., & Schlessinger, J. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0802896105 · Cited by 82
Aberrant activation of c-kit protects colon carcinoma cells against apoptosis and enhances their invasive potential.
Bellone, G., Carbone, A., Sibona, N., Bosco, O., Tibaudi, D., Smirne, C., Martone, T., Gramigni, C., Camandona, M., Emanuelli, G., et al. (2001) · PubMed · Cited by 81
The N‐terminal globular domain of Eph receptors is sufficient for ligand binding and receptor signaling
Labrador, J.-P., Brambilla, R., & Klein, R. (1997) · The EMBO Journal · doi:10.1093/emboj/16.13.3889 · Cited by 79
c-kitand its related genes in spermatogonial differentiation
Zhang, L., Tang, J., Haines, C. J., Feng, H. L., Lai, L., Teng, X., & Han, Y. (2011) · Spermatogenesis · doi:10.4161/spmg.1.3.17760 · Cited by 77
Decoupling the Functional Pleiotropy of Stem Cell Factor by Tuning c-Kit Signaling
Ho, C. C. M., Chhabra, A., Starkl, P. M., Schnorr, P. J., Wilmes, S., Moraga, I., Kwon, H.-S., Gaudenzio, N., Sibilano, R., Wehrman, T. S., et al. (2017) · Cell · doi:10.1016/j.cell.2017.02.011 · Cited by 75
Imatinib binding and cKIT inhibition is abrogated by the cKIT kinase domain I missense mutation Val654Ala
McLean, S. R., Gana‐Weisz, M., Hartzoulakis, B., Frow, R., Whelan, J., Selwood, D. L., & Boshoff, C. (2005) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-05-0070 · Cited by 71
One sequence, two folds: a metastable structure of CD2.
Murray, A. J., Lewis, S. J., Barclay, A. N., & Brady, R. L. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.16.7337 · Cited by 72
Human Stem Cell Factor Dimer Forms a Complex with Two Molecules of the Extracellular Domain of Its Receptor, Kit
Philo, J. S., Wen, J., Wypych, J., Schwartz, M. G., Mendiaz, E. A., & Langley, K. E. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.12.6895 · Cited by 71
Characterization of the Extracellular Domain in Vascular Endothelial Growth Factor Receptor‐1 (Flt‐1 Tyrosine Kinase)
Tanaka, K., Yamaguchi, S., Sakaue-Sawano, A., & Shibuya, M. (1997) · Japanese Journal of Cancer Research · doi:10.1111/j.1349-7006.1997.tb00463.x · Cited by 71
The Majority of Stem Cell Factor Exists as Monomer under Physiological Conditions
Hsu, Y., Wu, G., Mendiaz, E. A., Syed, R. S., Wypych, J., Toso, R. J., Mann, M. B., Boone, T. C., Narhi, L. O., Lu, H. S., et al. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.10.6406 · Cited by 70
Identification of the Residues in the Extracellular Region of KDR Important for Interaction with Vascular Endothelial Growth Factor and Neutralizing Anti-KDR Antibodies
Lü, D., Kussie, P. H., Pytowski, B., Persaud, K., Böhlen, P., Witte, L., & Zhu, Z. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.19.14321 · Cited by 69
Mechanism of Insulin and IGF‐I
MEYTS, P. D., Ursø, B., Christoffersen, C. T., & Shymko, R. M. (1995) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1995.tb26688.x · Cited by 66
Functional Importance of Platelet-derived Growth Factor (PDGF) Receptor Extracellular Immunoglobulin-like Domains
Lokker, N. A., O'Hare, J. P., Barsoumian, A., Tomlinson, J. E., Ramakrishnan, V., Fretto, L. J., & Giese, N. A. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.52.33037 · Cited by 63
Activating Mutation in the Catalytic Domain of c-kit Elicits Hematopoietic Transformation by Receptor Self-Association Not at the Ligand-Induced Dimerization Site
Tsujimura, T., Hashimoto, K., Kitayama, H., Ikeda, H., Sugahara, H., Matsumura, I., Kaisho, T., Terada, N., Kitamura, Y., & Kanakura, Y. (1999) · Blood · doi:10.1182/blood.v93.4.1319 · Cited by 61
Role of the time factor in signaling specificity: Application to mitogenic and metabolic signaling by the insulin and insulin-like growth factor-I receptor tyrosine kinases
MEYTS, P. D., Christoffersen, C. T., Ursø, B., Wallach, B. J., Grønskov, K., Yakushiji, F., & Shymko, R. M. (1995) · Metabolism · doi:10.1016/0026-0495(95)90214-7 · Cited by 59
Immunoglobulin-like Domain 4-mediated Receptor-Receptor Interactions Contribute to Platelet-derived Growth Factor-induced Receptor Dimerization
Omura, T., Heldin, C., & Östman, A. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.19.12676 · Cited by 59
Antagonistic VEGF variants engineered to simultaneously bind to and inhibit VEGFR2 and α v β 3 integrin
Papo, N., Silverman, A. P., Lahti, J. L., & Cochran, J. R. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1016635108 · Cited by 58
Solution structure of the VEGF-binding domain of Flt-1: comparison of its free and bound states 1 1Edited by P. E. Wright
Starovasnik, M. A., Christinger, H. W., Wiesmann, C., Champe, M., de Vos, A. M., & Skelton, N. J. (1999) · Journal of Molecular Biology · doi:10.1006/jmbi.1999.3134 · Cited by 56
A novel mutation within the extracellular domain of TrkA causes constitutive receptor activation
Arévalo, J. C., Conde, B., Hempstead, B. L., Chao, M. V., Martı́n-Zanca, D., & Pérez, P. (2001) · Oncogene · doi:10.1038/sj.onc.1204215 · Cited by 55
The SCF/c-KIT system in the male: Survival strategies in fertility and cancer
Cardoso, H. J., Figueira, M. I., Correia, S., Vaz, C. V., & Socorro, S. (2014) · Molecular Reproduction and Development · doi:10.1002/mrd.22430 · Cited by 51
Fluorescence Resonance Energy Transfer Reveals Interleukin (IL)-1-dependent Aggregation of IL-1 Type I Receptors That Correlates with Receptor Activation
Guo, C., Dower, S., Holowka, D., & Baird, B. A. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.46.27562 · Cited by 52
Expression of c-Kit receptor tyrosine kinase and effect on β-cell development in the human fetal pancreas
Li, J., Quirt, J., Do, H. Q., Lyte, K., Fellows, F., Goodyer, C. G., & Wang, R. (2007) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00172.2007 · Cited by 50
Kinase Insert Domain Receptor (KDR) Extracellular Immunoglobulin-like Domains 4–7 Contain Structural Features That Block Receptor Dimerization and Vascular Endothelial Growth Factor-induced Signaling
Tao, Q., Backer, M. V., Backer, J. M., & Terman, B. I. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m100763200 · Cited by 50
KIT (c-kit oncogene product) pathway is constitutively activated in human testicular germ cell tumors
Nakai, Y., Nonomura, N., Oka, D., Shiba, M., Arai, Y., Nakayama, M., Inoue, H., Nishimura, K., Aozasa, K., Mizutani, Y., et al. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.09.042 · Cited by 49
c-kit expression profile and regulatory factors during spermatogonial stem cell differentiation
Zhang, L., Tang, J., Haines, C. J., Feng, H. L., Lai, L., Teng, X., & Han, Y. (2013) · BMC Developmental Biology · doi:10.1186/1471-213x-13-38 · Cited by 48
Control of KIT signalling in male germ cells: what can we learn from other systems?
Mithraprabhu, S., & Loveland, K. L. (2009) · Reproduction · doi:10.1530/rep-08-0537 · Cited by 48
Production of the Soluble Form of KIT, s-KIT, Abolishes Stem Cell Factor-Induced Melanogenesis in Human Melanocytes
Kasamatsu, S., Hachiya, A., Higuchi, K., Ohuchi, A., Kitahara, T., & Boissy, R. E. (2008) · Journal of Investigative Dermatology · doi:10.1038/jid.2008.9 · Cited by 46
Structure and function of the T-cell receptor: insights from X-ray crystallography
Fields, B. A., & Mariuzza, R. A. (1996) · Immunology Today · doi:10.1016/0167-5699(96)10020-7 · Cited by 46
Is CTLA-4 a negative regulator for T-cell activation?
Liu, Y. (1997) · Immunology Today · doi:10.1016/s0167-5699(97)01170-5 · Cited by 45
Interactions between Brain-derived Neurotrophic Factor and the TRKB Receptor
Haniu, M., Montestruque, S., Bures, E. J., Talvenheimo, J., Toso, R. J., Lewis-Sandy, S., Welcher, A. A., & Rohde, M. F. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.40.25296 · Cited by 41
Estrogenic regulation of testicular expression of stem cell factor and c-kit: implications in germ cell survival and male fertility
Correia, S., Alves, M. G., Cavaco, J. E. B., Oliveira, P. F., & Socorro, S. (2014) · Fertility and Sterility · doi:10.1016/j.fertnstert.2014.04.009 · Cited by 39
Systemic Mastocytosis
Robyn, J. A., & Metcalfe, D. D. (2006) · Advances in immunology · doi:10.1016/s0065-2776(05)89005-4 · Cited by 38
Structural insights into Met receptor activation
Niemann, H. H. (2011) · European Journal of Cell Biology · doi:10.1016/j.ejcb.2010.11.014 · Cited by 36
Ligand-binding sites in Ig-like domains of receptor tyrosine kinases
Wiesmann, C., Muller, Y. A., & de Vos, A. M. (2000) · Journal of Molecular Medicine · doi:10.1007/s001090000082 · Cited by 34
Immobilized anti-KIT monoclonal antibody induces ligand-independent dimerization and activation of Steel factor receptor: biologic similarity with membrane-bound form of Steel factor rather than its soluble form
Kurosawa, K., Miyazawa, K., Gotoh, A., Katagiri, T., Nishimaki, J., Ashman, L., & Toyama, K. (1996) · Blood · doi:10.1182/blood.v87.6.2235.bloodjournal8762235 · Cited by 34
Differential Expression of Receptors for Hemopoietic Growth Factors on Subsets of CD34+Hemopoietic Cells
Wognum, A. W., Jong, M. O. D., & Wagemaker, G. (1996) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.3109/10428199609045710 · Cited by 34
Identification of the Extracellular Domains of Flt-1 That Mediate Ligand Interactions
Cunningham, S. A., STEPHAN, C. C., Arrate, M. P., Ayer, K. G., & Brock, T. A. (1997) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1997.6156 · Cited by 33
Structural basis for KIT receptor tyrosine kinase inhibition by antibodies targeting the D4 membrane-proximal region
Reshetnyak, A. V., Nelson, B., Shi, X., Boggon, T. J., Pavlenco, A., Mandel-Bausch, E. M., Tomé, F., Suzuki, Y., Sidhu, S. S., Lax, I., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1317118110 · Cited by 32
Synergistic Growth of Stem Cell Factor and Granulocyte Macrophage Colony-stimulating Factor Involves Kinase-dependent and -independent Contributions from c-Kit
Lennartsson, J., Shivakrupa, R., & Linnekin, D. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m404085200 · Cited by 31
Synthetic Peptides of CD66a Stimulate Neutrophil Adhesion to Endothelial Cells
Skubitz, K. M., Campbell, K. D., & Skubitz, A. P. N. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.8.4257 · Cited by 30
THE FIFTH IMMUNOGLOBULIN-LIKE DOMAIN OF THE KIT RECEPTOR IS REQUIRED FOR PROTEOLYTIC CLEAVAGE FROM THE CELL SURFACE
Broudy, V. C., Lin, N. L., & Sabath, D. F. (2001) · Cytokine · doi:10.1006/cyto.2001.0907 · Cited by 29
Antibodies to domains II and III of the IL-1 receptor accessory protein inhibit IL-1 beta activity but not binding: regulation of IL-1 responses is via type I receptor, not the accessory protein.
Yoon, D., & Dinarello, C. A. (1998) · PubMed · Cited by 29
A survival Kit for pancreatic beta cells: stem cell factor and c-Kit receptor tyrosine kinase
Feng, Z., Riopel, M., Popell, A., & Wang, R. (2015) · Diabetologia · doi:10.1007/s00125-015-3504-0 · Cited by 27
Expression of KIT in the ovary, and the role of somatic precursor cells
Merkwitz, C., Lochhead, P. J., Tsikolia, N., Koch, D., Sygnecka, K., Sakurai, M., Spanel‐Borowski, K., & Ricken, A. M. (2011) · Progress in Histochemistry and Cytochemistry · doi:10.1016/j.proghi.2011.09.001 · Cited by 26
Antibodies to Domains II and III of the IL-1 Receptor Accessory Protein Inhibit IL-1β Activity But Not Binding: Regulation of IL-1 Responses Is Via Type I Receptor, Not the Accessory Protein
Yoon, D., & Dinarello, C. A. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.160.7.3170 · Cited by 26
Expression of the ErbB Family of Receptors in Ovarian Cancer
Scoccia, B., Lee, Y. M., Niederberger, C., & Ilekis, J. V. (1998) · Journal of the Society for Gynecologic Investigation · doi:10.1016/s1071-5576(98)00006-9 · Cited by 25
Therapeutic targeting of receptor tyrosine kinases in lung cancer
Choong, N. W., Ma, P. C., & Salgia, R. (2005) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.9.3.533 · Cited by 24
An Antibody Reactive with Domain 4 of the Platelet-derived Growth Factor β Receptor Allows BB Binding while Inhibiting Proliferation by Impairing Receptor Dimerization
Shulman, T., Sauer, F. G., Jackman, R. M., Chang, C. N., & Landolfi, N. F. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.28.17400 · Cited by 24
SCF-KIT Pathway in Human Epidermal Melanocyte Homeostasis
Longley, B. J., & Carter, E. L. (1999) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.1999.00643.x · Cited by 24

Authors: Blechman, J. M., Lev, S., Barg, J., Eisenstein, M., Vaks, B., Vogel, Z., Givol, D., & Yarden, Y.
Affiliations: Weizmann Institute of Science (IL)
Tel Aviv University (IL)
ORCID: Lev, Sima
Eisenstein, Miriam
Yarden, Yosef
Venue: Cell
Publisher: Elsevier BV
Published: 1995-01
Volume: 80
Issue: 1
Pages: 103-113
ISSN: 0092-8674 (ISSN-L)
DOI: 10.1016/0092-8674(95)90455-7
OpenAlex: W2054154416
Cited by: 156
References: 37
Citations by year: 2025: 2 · 2024: 1 · 2023: 1 · 2021: 1 · 2018: 2 · 2017: 3 · 2016: 1 · 2015: 1 · 2014: 6 · 2013: 5 · 2012: 1
FWCI: 6.19
Type: journal article
Language: en
Open access: hybrid
doi.org
Licence: cc-by
www.elsevier.com/tdm/userlicense/1.0/ (tdm)
www.elsevier.com/open-access/userlicense/1.0/ (vor, 6772 d)
Locations: Cell (publishedVersion, cc-by)
PubMed (publishedVersion)
Funders: Israel Cancer Research Fund
Topics: Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Receptor Mechanisms and Signaling
Life Sciences › Immunology and Microbiology › Immunology › Cytokine Signaling Pathways and Interactions
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Kinase Regulation and GTPase Signaling
Keywords: CD117, receptor dimerization, ligand binding, signal transduction, receptor tyrosine kinase, domain deletion
MeSH terms: Animals, Antibodies, Monoclonal, Base Sequence, Binding Sites, Cells, Cultured, Enzyme Activation, Humans, Ligands, Models, Molecular, Molecular Sequence Data, Mutation, Proto-Oncogene Proteins, Solubility, Signal Transduction, Receptors, Colony-Stimulating Factor, Hematopoietic Cell Growth Factors, Epitope Mapping, Proto-Oncogene Proteins c-kit, Stem Cell Factor, Receptor Protein-Tyrosine Kinases, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

The fourth immunoglobulin domain of the stem cell factor receptor couples ligand binding to signal transduction

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks